Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys

AIDS Research and Human Retroviruses

Volumn 16, Issue 17, 2000, Pages 1895-1908

  Croix, D A ^a   Capuano III, S ^a   Simpson, L ^b   Fallert, B A ^c   Fuller, C L ^c   Klein, E C ^d   Reinhart, T A ^c   Murphey Corb, M ^a   Flynn, J L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIREMIA; VIRUS LOAD; VIRUS TITRATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MYCOBACTERIUM BOVIS; RECEPTORS, CCR5; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPLEEN; SURVIVORS; T-LYMPHOCYTES; TUBERCULOSIS; VIRAL LOAD;

EID: 0034694006     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050195856     Document Type: Article

References (57)

1. Incidence of tuberculosis in the United States among HIV-infected persons
2. Tuberculosis, AIDS, and death among substance abusers on welfare in New York City
3. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
4. Accelerated course of human immunodeficiency virus infection after tuberculosis
5. The emergence of drug-resistant tuberculosis in New York City
6. Mycobacterium tuberculosis enhances human immunodeficiency virus type-1 replication in the lung
7. Effect of Mycobacterium tuberculosis on HIV replication: Role of immune activation
8. Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus
9. Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro
10. Immune activation is a dominant factor in the pathogenesis of African AIDS
11. Influence of microbial infections on the progression of HIV disease
12. HIV-1 viraemia and influenza
13. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumoccal vaccine
14. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
15. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid
16. Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques
17. The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines
18. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination
19. Mycobacterium bovis bacille Calmette-Guerin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: A role of persistent T cell activation in AIDS pathogenesis
20. The safety of bacille Calmette-Guerin vaccination in HIV infection and AIDS
21. Disseminated bacille Calmette-Guerin disease after vaccination: Case report and review
22. Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments
23. Competitive nested polymerase chain reaction for quantification of human MDR 1 gene expression
24. Colorimetric detection of competitive PCR products for quantification in hepatitis C viremia
25. Crossreactivity with HTLV-III/LAV and molecular cloning of STLV-III from African green monkeys
26. A simple and rapid method for generating a deletion by PCR
27. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
28. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
29. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages
30. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
31. Differential inhibition of human immunodeficiency virus type 1 fusion, gp 120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
32. Simian immuno-deficiency virus burden in tissues and cellular compartments during clinical latency and AIDS
33. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
34. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses
35. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
36. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
37. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
38. Activation of virus replication after vaccination of HIV-1-infected individuals
39. Bacille Calmette-Guerin immunization in normal healthy adults
40. A historical and molecular phylogeny of BCG strains
41. Identification of a major co-receptor for primary isolates of HIV-1
42. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
43. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
44. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
45. CCR5 levels and expression pattern correlates with infectability by macrophage-tropic HIV-1, in vitro
46. C-C Chemokines released by LPS-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells
47. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
48. An essential role for interferony in resistance to Mycobacterium tuberculosis infection
49. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
50. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
51. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
52. Simian immunodeficiency virus infection of CD8+ lymphocytes in vivo
53. CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro
54. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression
55. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection